KEAP1 and neurodegenerative disease: The activation of the Keap1-Nrf2-ARE signaling pathway in neurodegenerative disease models has been shown to provide cellular antioxidant protection, reduce neuronal damage, and delay disease progression (Chakkittukandiyil et al., 2024).